Skip to content
zameds

Tranexamic acid

Sold as Tranic, Morwak, Cynex, Fibtin, Tranexamic acid PHARMC, Transun iv, Klotigo, Hemopron, Tranexamic pharma-q, Cykloclot, Immatra, Rubinex, Tranmenxio iv, Zamicron, Stranan, Mantexora, Cyklodus, Cyklokapron iv, Cyklokapron t

S4
Loading the molecular structure
C8H15NO2157.21 g/mol

4-(Aminomethyl)cyclohexane-1-carboxylic acid

Drag to rotate. Structure from PubChem CID 5526.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
17
Registrations
21
Schedule source
Consolidated Schedules 06 July 2026

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Acino Pharma (Pty) LtdTranic, Transun ivNot stated410223, 490445S4None
Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr. Reddy’s Laboratories (Pty) Ltd.Morwak250mgg, 500mg,750mg410742S4PI
Ranbaxy Pharmaceutical (Pty) LtdCynex500 mg430263S4None
Pharmacare limited û woodmeadCertificate held by Pharmacare limitedFibtin500 mg/5 mL480251S4PIPIL
Pharmacorp (Pty) LtdTranexamic acid PHARMC100 mg/mL481085S4PIPIL
Pharma Dynamics (Pty) LtdKlotigo500, 1000520806, 520807S4PIPIL
Macleods Pharmaceuticals SA (Pty) LtdCertificate held by Abex Pharmaceutica (Pty) LtdHemopron500, 500 mg, 1 000 mg520808, 520809S4PIPIL
Pharma-q Holdings (Pty) LtdTranexamic pharma-q1000 mg540223S4PIPIL
Juno Pharma SA (Pty) LtdCertificate held by Kahma Biotech (Pty) LtdCykloclot100 mg540886S4PIPIL
Cipla Medpro (Pty) LtdCertificate held by Ruby Pharmaceuticals (Pty) LtdImmatra100mg550127S4PIPIL
Ruby Pharmaceuticals (Pty) LtdRubinex100mg550128.127S4PIPIL
Biotech Laboratories (Pty) LtdTranmenxio iv500mg560497S4PIPIL
Ascendis Pharma (Pty) LtdZamicroninjection560639S4None
Austell Pharmaceuticals (Pty) LtdStrananinjection560640.639S4None
RBC Pharmaceuticals (Pty) LtdMantexoraNot stated570573S4None
Zydus Healthcare (Pty) LtdCyklodusNot stated590143S4None
Pfizer Laboratories (Pty) LtdCyklokapron iv, Cyklokapron t500H0806, H0807S4None

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Tranic

EACH TABLET CONTAINS TRANEXAMIC ACID 500,0 mg

Not listed41022341/8.1/0223RegisteredS4None
Morwak

EACH TABLET CONTAINS TRANEXAMIC ACID 500,0 mg

250mgg, 500mg,750mgTablets41074241/8.1/0742Approved 11 December 2019RegisteredS4PI
Cynex 500 MG injection

EACH 5,0 ml AMPOULE CONTAINS TRANEXAMIC ACID 500,0 mg

500 mgInjection43026343/8.1/0263RegisteredS4None
Fibtin injection

EACH 5 mL AMPOULE CONTAINS TRANEXAMIC ACID 500,0 mg

500 mg/5 mLSolution for injection.48025148/8.1/0251Approved 28 April 2021RegisteredS4PIPIL
Tranexamic acid 100 mg/ml PHARMC

EACH 5 mL AMPOULE CONTAINS TRANEXAMIC ACID 500,0 mg

100 mg/mLSolution for injection.48108548/8.1/1085Approved 17 July 2024RegisteredS4PIPIL
Transun iv

Each 5 ml Ampoule contains: Tranexamic Acid

Not listed49044549/8.1/0445RegisteredS4None
Klotigo 500500Solution for injection/ infusion52080652/8.1/0806Approved 29 January 2025RegisteredS4PIPIL
Klotigo 10001000Solution for injection/ infusion52080752/8.1/0807Approved 29 January 2025RegisteredS4PIPIL
Hemopron 500500Solution for injection/infusion52080852/8.1/0808Approved 30 May 2023RegisteredS4PIPIL
Hemopron 1 000500 mg, 1 000 mgSolution for injection/infusion52080952/8.1/0809Approved 30 May 2023RegisteredS4PIPIL
Tranexamic injection pharma-q1000 mgInjection54022354/8.1/0223Approved 24 April 2022RegisteredS4PIPIL
Cykloclot 100 mg/ml

TRANEXAMIC ACID

100 mgTablet54088654/8.1/0886Approved 7 February 2023RegisteredS4PIPIL
Immatra

EACH 1,0 ml SOLUTION CONTAINS TRANEXAMIC ACID 100,0 mg

100mgSolution for injection55012755/8.1/0127Approved 29 March 2022RegisteredS4PIPIL
Rubinex

EACH 1,0 ml SOLUTION CONTAINS TRANEXAMIC ACID 100,0 mg

100mgSolution for injection550128.12755/8.1/0128.127Approved 29 March 2022RegisteredS4PIPIL
Tranmenxio iv

EACH AMPOULE CONTAINS TRANEXAMIC ACID 500,0 mg

500mgSolution for injection/infusion56049756/8.1/0497Approved 29 March 2022RegisteredS4PIPIL
Zamicron injection

EACH AMPOULE CONTAINS TRANEXAMIC ACID 500,0 mg

Injection56063956/8.1/0639RegisteredS4None
Stranan injection

EACH AMPOULE CONTAINS TRANEXAMIC ACID 500,0 mg

Injection560640.63956/8.1/0640.639RegisteredS4None
Mantexora

EACH 5,0 ml SOLUTION CONTAINS: TRANEXAMIC ACID 500,0 mg

Not listed57057357/8.1/0573RegisteredS4None
Cyklodus

EACH TABLET CONTAINS: TRANEXAMIC ACID 500,0 mg

Not listed59014359/8.1/0143RegisteredS4None
Cyklokapron iv 500

EACH 5 ml SOLUTION CONTAINS TRANEXAMIC ACID 500 mg

500H0806H/8.1/806RegisteredS4None
Cyklokapron t 500

EACH TABLET CONTAINS TRANEXAMIC ACID 500 mg

500H0807H/8.1/807RegisteredS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Tranexamic acid

  • S4: Tranexamic acid

    Consolidated Schedules 06 July 2026, line 8259

Pharmacological class: Coagulants, haemostatics. (class 8.1)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Morwak, Dr Reddyæs Laboratories (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsMorwak, Dr Reddyæs Laboratories (Pty) LtdPatient information leaflet (PIL)For patients and carersFibtin injection, Pharmacare limited û woodmead

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles